Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
1 Bekeken
• 07/14/23
0
0
insluiten
administrator
abonnees
Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties